Results 101 to 110 of about 88,400 (300)

Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia [PDF]

, 2017
Background With the emergence of macrolide resistance, concerns about the efficacy of macrolides for the treatment of Mycoplasma pneumoniae (MP) pneumonia in children have been raised.
Hoan Jong Lee, Ki Bae Hong, Choi, Young Hoon, Young Min Ahn, Hyunju Lee, Byung Wook Eun, Ji Young Park, Kim, Woo Sun, Lee, Hoan Jong, Yun, Ki Wook, Ahn, Young Min, Hong, Ki Bae, Woo Sun Kim, Lee, Hyunju, Eun, Byung Wook, Choi, Eun Hwa, Eun Hwa Choi, Eun Young Cho, Hwa Jin Cho, In Ae Yoon, Ki Wook Yun, Cho, Eun Young, Young Hoon Choi, Yoon, In Ae, Park, Ji Young, Cho, Hwa Jin   +25 more
core   +1 more source

Disease Burden, Temporal Trends, and Key Influencing Factors of Lower Respiratory Infections in Asia, 1990–2023: Based on GBD 2023

Med Research, EarlyView.
In 2023, marked regional heterogeneity was observed across Asia: South Asia carried the highest incidence and prevalence, Central Asia had the highest DALY rate, Southeast Asia bore the highest mortality and East Asia and High‐income Asia‐Pacific generally had lower rates.
Lingxia Zhang, Yufeng Li, Enjun Dong, Mingming Zhang, Yuan Tian, Shuang Zhou, Ruizi Ni, Yajing An, Xiaojuan Qin, Bingrui Gao, Qi Shen, Weiguo Sun, Yanhua Liu, Wenping Gong   +13 more
wiley   +1 more source

Novel mechanism responsible for high-level macrolide resistance in Moraxella catarrhalis

, 2018
Ayako Kasai,1 Ayaka Ohta,1 Yuina Maeda,1 Kageto Yamada,2 Kazuyuki Tao,3 Ryoichi Saito1 1Department of Molecular Microbiology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8510, Japan ...
Tao K, Saito R, Maeda Y, Ohta A, Kasai A, Yamada K   +5 more
core  

Senotherapeutics for Knee Osteoarthritis

Medicinal Research Reviews, EarlyView.
ABSTRACT Osteoarthritis (OA) is a chronic disease that imposes a significant economic burden and deteriorates quality of life. Nevertheless, current therapeutic options for OA are limited to symptomatic remedies. As such, there is a high interest in novel methods for treating or preventing OA.
Ezgi Duman, Girish Pattappa, Patrick Pann, Stephan Reppenhagen, Maximilian Rudert, Peter Angele, Denitsa Docheva   +6 more
wiley   +1 more source

NEWER MACROLIDES [PDF]

Medical Journal Armed Forces India, 1996
S K, Sharma, A S, Kasthuri
openaire   +2 more sources

Hidden Epidemic of Macrolide-resistant Pneumococci

, 2005
Community-acquired respiratory tract infections (RTIs) account for a substantial proportion of outpatient antimicrobial drug prescriptions worldwide. Concern over the emergence of multidrug resistance in pneumococci has largely been focused on penicillin-
Keith P. Klugman, John R. Lonks
core   +1 more source

Clinical outcomes of empirical topical nifuratel or nitrofurantoin in Streptococcus pyogenes vulvovaginitis: A retrospective study

International Journal of Gynecology &Obstetrics, EarlyView.
Marek Stefan, Kristyna Krogh, Jaroslava Zikova, Marta Novackova, Marcela Krutova   +4 more
wiley   +1 more source

Artificial Intelligence‐Driven Natural Product Drug Discovery: From Computational Genome Mining to Clinical Translation

Medicinal Research Reviews, EarlyView.
ABSTRACT Natural products (NPs) have historically yielded numerous therapeutic agents, yet their integration into modern drug discovery has been constrained by chemical complexity, low abundance, laborious dereplication, and limited target annotation.
Antonio Lavecchia
wiley   +1 more source

Macrolides

, 2014
Citation: 'macrolides' in the IUPAC Compendium of Chemical Terminology, 3rd ed.; International Union of Pure and Applied Chemistry; 2006. Online version 3.0.1, 2019. 10.1351/goldbook.M03663 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
A. Bryskier, E. Bergogne-Bérézin
openaire   +2 more sources

Macrolide Resistance in Streptococcus pneumoniae

, 2016
Streptococcus pneumoniae is a common commensal and an opportunistic pathogen. Suspected pneumococcal upper respiratory infections and pneumonia are often treated with macrolide antibiotics.
Max R Schroeder, David S. Stephens
core   +1 more source